Promea Therapeutics Private Limited, a active private limited company, was established on 31 July 2017 in Patancheru, Telangana, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U24304TG2017PTC118617. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹3.86 Cr.
It upholds a compliant status. Employing 174 professional, Its leadership includes Rajesh Reddy Tummuru (Director), Pooja Aakanksha Gaddam (Director). Past directors included Gaddam Reddy Ranjith. It holds ₹57.91 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. M4, Medical Device Park, Sultanpur (V), Patancheru, Telangana, 502319.
U24304TG2017PTC118617
118617
31 July 2017
₹4.00 Cr
₹3.86 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Promea Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Reddy Tummuru | Director | 09 Oct 2017 | Current |
| Pooja Aakanksha Gaddam | Director | 31 Jul 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Promea Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 98.06% increase. The company also saw a substantial fall in profitability, with a 17198.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 28.66%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Promea Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹579,140,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jul 2024 | Others | ₹36.08 Cr | Open |
| 29 Dec 2022 | Axis Bank Limited | ₹1.75 Cr | Open |
| 24 May 2021 | Others | ₹20.08 Cr | Open |
Explore comprehensive loan charge details -
Promea Therapeutics has a workforce of 174 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Promea Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Promea Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 36.08 Cr registered on 01 Jul 2024 with Charge ID 100955463 was modified on 28 May 2025. was documented.
The activity A charge with Others of Rs. 20.08 Cr registered on 24 May 2021 with Charge ID 100470484 was modified on 30 Jan 2025. was completed.
The activity Promea Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge with Others amounted to Rs. 36.08 Cr with Charge ID 100955463 was registered on 01 Jul 2024. was recorded as a recent event.
The activity Promea Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on A charge with Axis Bank Limited amounted to Rs. 1.75 Cr with Charge ID 100695360 was registered on 29 Dec 2022. was documented.
The CIN of Promea Therapeutics Private Limited is U24304TG2017PTC118617.
Promea Therapeutics Private Limited is headquartered at Plot No. M4, Medical Device Park, Sultanpur (V), Patancheru, Telangana, 502319.
Promea Therapeutics Private Limited was incorporated on 31 July 2017.
The current directors of Promea Therapeutics Private Limited are
The primary industry of Promea Therapeutics Private Limited is Manufacturing.
Promea Therapeutics Private Limited is unlisted.
The authorized capital of Promea Therapeutics Private Limited is ₹4.00 Cr, and the paid-up capital is ₹3.86 Cr.
The compliance status of Promea Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX